Joseph P. Tizzano

2.6k citations

37 papers · 2.1k indexed · h-index 20

Cellular and Molecular Neuroscience top 1%
Molecular Biology top 10%
Cognitive Neuroscience top 5%
Organic Chemistry top 10%
Pharmacology top 5%

Co-authors: Darryle D. Schoepp Kelly I. Griffey James A. Monn David R. Helton Bryan G. Johnson Rebecca A. Wright Mary Jeanne Kallman Phil Skolnick
Topics: Neuroscience and Neuropharmacology Research (29 papers)Receptor Mechanisms and Signaling (7 papers)Neurotransmitter Receptor Influence on Behavior (6 papers)
Cited by: Cellular and Molecular Neuroscience Biological Psychiatry Behavioral Neuroscience
Journals: Annals of the New York Academy of Sciences Journal of Medicinal Chemistry Journal of Pharmacology and Experimental Therapeutics
Partner nations: United States China Spain

In The Last Decade

Joseph P. Tizzano

36 papers receiving 2.1k citations

Peers

Countries citing papers authored by Joseph P. Tizzano

Since Specialization

Citations

This map shows the geographic impact of Joseph P. Tizzano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph P. Tizzano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph P. Tizzano more than expected).

Fields of papers citing papers by Joseph P. Tizzano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph P. Tizzano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph P. Tizzano. The network helps show where Joseph P. Tizzano may publish in the future.

Co-authorship network of co-authors of Joseph P. Tizzano

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph P. Tizzano. A scholar is included among the top collaborators of Joseph P. Tizzano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph P. Tizzano. Joseph P. Tizzano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Preclinical Evaluation of the Abuse Potential of the Analgesic Bicifadine 2009 ·Journal of Pharmacology and Experimental Therapeutics ·Katherine L. Nicholson,Robert L. Balster,Krystyna Gołembiowska,(unknown),Joseph P. Tizzano,Phil Skolnick,Anthony S. Basile	11
2	In vivo pharmacological characterization of the structurally novel, potent, selective mGlu2/3 receptor agonist LY404039 in animal models of psychiatric disorders 2007 ·Psychopharmacology ·Linda M. Rorick‐Kehn,Bryan G. Johnson,(unknown),Craig R. Salhoff,Jeffrey M. Witkin,Kenneth W. Perry,Kelly I. Griffey,Joseph P. Tizzano,James A. Monn,David L. McKinzie,Darryle D. Schoepp	131
3	Preclinical and Clinical Pharmacology of DOV 216,303, a “Triple” Reuptake Inhibitor 2006 ·CNS Drug Reviews ·Phil Skolnick,Philip A. Krieter,Joseph P. Tizzano,Anthony S. Basile,Piotr Popik,Pál Czobor,Arnold Lippa	88
4	Metabotropic glutamate 2 receptor potentiators: receptor modulation, frequency-dependent synaptic activity, and efficacy in preclinical anxiety and psychosis model(s) 2005 ·Psychopharmacology ·Michael P. Johnson,David A. Barda,Thomas C. Britton,Renee Emkey,William J. Hornback,G. Erik Jagdmann,David L. McKinzie,Eric S. Nisenbaum,Joseph P. Tizzano,Darryle D. Schoepp	126
5	The anxiolytic action of mGlu2/3 receptor agonist, LY354740, in the fear-potentiated startle model in rats is mechanistically distinct from diazepam 2002 ·Pharmacology Biochemistry and Behavior ·Joseph P. Tizzano,Kelly I. Griffey,Darryle D. Schoepp	67
6	Biarylpropylsulfonamides as Novel, Potent Potentiators of 2-Amino-3- (5-methyl-3-hydroxyisoxazol-4-yl)- propanoic Acid (AMPA) Receptors 2000 ·Journal of Medicinal Chemistry ·Paul L. Ornstein,Dennis M. Zimmerman,M. Brian Arnold,Thomas J. Bleisch,Buddy E. Cantrell,(unknown),Hamideh Zarrinmayeh,Stephen Baker,Mary Gates,Joseph P. Tizzano,David Bleakman,Allan Mandelzys,(unknown),Ken H. Ho,(unknown),Rajender K. Kamboj	62
7	LY354740: a metabotropic glutamate receptor agonist which ameliorates symptoms of nicotine withdrawal in rats 1997 ·Neuropharmacology ·David R. Helton,Joseph P. Tizzano,James A. Monn,Darryle D. Schoepp,Mary Jeanne Kallman	77
8	Agonists and antagonists of metabotropic glutamate receptor subtypes as anticonvulsant agents 1996 ·Neuropharmacology ·Joseph P. Tizzano,Kelly I. Griffey,David R. Helton,Mary Jeanne Kallman,James A. Monn,Darryle D. Schoepp	1
9	Selective protection against AMPA- and kainate-evoked neurotoxicity by (3S,4aR,6R,8aR)-6-[2-(1(2)H-tetrazole-5-yl)ethyl]decahydroisoquinoline-3-carboxylic acid (LY293558) and its racemate (LY215490) 1996 ·Journal of Neural Transmission ·Darryle D. Schoepp,Craig R. Salhoff,Kimberly S. Fuson,Aida Sacaan,Joseph P. Tizzano,Paul L. Ornstein,Patrick C. May	10
10	Receptor Subtypes Linked to Metabotropic Glutamate Receptor Agonist‐Mediated Limbic Seizures in Mice 1995 ·Annals of the New York Academy of Sciences ·Joseph P. Tizzano,Kelly I. Griffey,Darryle D. Schoepp	20
11	In vitro and in vivo antagonism of AMPA receptor activation by (3s,4ar,6r,8ar)-6-[2-(1(2)h-tetrazole-5-yl)ethyl]decahydroisoquinoline-3-carboxylic acid 1995 ·Neuropharmacology ·Darryle D. Schoepp,David Lodge,David Bleakman,J. David Leander,Joseph P. Tizzano,Rebecca A. Wright,Andrew Palmer,Craig R. Salhoff,Paul L. Ornstein	59
12	Reversible and Irreversible Neuronal Injury Induced by Intrahippocampal Infusion of the mGluR Agonist 1S,3R-ACPD in the Rat 1995 ·PubMed ·Darryle D. Schoepp,Joseph P. Tizzano,Rebecca A. Wright,Andrew S. Fix	12
13	Blockade of the second messenger functions of the glutamate metabotropic receptor is associated with degenerative changes in the retina and brain of immature rodents 1995 ·Neuropharmacology ·Madelon T. Price,Corrado Romano,Andrew S. Fix,Joseph P. Tizzano,John W. Olney	14
14	(3SR,4aRS,6SR,8aRS)-6-(1H-Tetrazol-5-yl)decahydroisoquinoline-3-carboxylic Acid, a Novel, Competitive, Systemically Active NMDA and AMPA Receptor Antagonist 1995 ·Journal of Medicinal Chemistry ·Paul L. Ornstein,M. Brian Arnold,(unknown),J. David Leander,Joseph P. Tizzano,David Lodge,Darryle D. Schoepp	16
15	Neonatal exposure to d,l-2-amino-3-phosphonopropionate (d,l-AP3) produces lesions in the eye and optic nerve of adult rats 1993 ·Developmental Brain Research ·Andrew S. Fix,Darryle D. Schoepp,John W. Olney,W. A. Vestre,Kelly I. Griffey,Joel A. Johnson,Joseph P. Tizzano	10
16	Nicotine withdrawal: a behavioral assessment using schedule controlled responding, locomotor activity, and sensorimotor reactivity 1993 ·Psychopharmacology ·David R. Helton,(unknown),Joseph P. Tizzano,Kurt Rasmussen	70
17	Developmental toxicity of gemcitabine, an antimetabolite oncolytic, administered during gestation to CD‐1 mice 1993 ·Teratology ·(unknown),Joseph P. Tizzano,(unknown),Glen C. Todd	10
18	Intracerebral 1S,3R-1-aminocyclopentane-1,3-dicarboxylic acid (1S,3R-ACPD) produces limbic seizures that are not blocked by ionotropic glutamate receptor antagonists 1993 ·Neuroscience Letters ·Joseph P. Tizzano,Kelly I. Griffey,(unknown),Andrew S. Fix,David R. Helton,Darryle D. Schoepp	43
19	Developmental toxicity of the dopamine agonist pergolide mesylate in CD-1 mice. I: Gestational exposure 1991 ·Neurotoxicology and Teratology ·J Buelke-Sam,Richard A. Byrd,(unknown),Joseph P. Tizzano,(unknown)	10
20	Developmental toxicity of the dopamine agonist pergolide mesylate in CD-1 mice. II: Perinatal and postnatal exposure 1991 ·Neurotoxicology and Teratology ·J Buelke-Sam,(unknown),Joseph P. Tizzano,(unknown)	7

About Joseph P. Tizzano

Joseph P. Tizzano is a scholar working on Cellular and Molecular Neuroscience, Developmental Neuroscience and Behavioral Neuroscience, having authored 37 papers that have together received 2.1k indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (29 papers), Receptor Mechanisms and Signaling (7 papers) and Neurotransmitter Receptor Influence on Behavior (6 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (1.7k citations), Biological Psychiatry (195 citations) and Behavioral Neuroscience (87 citations). Joseph P. Tizzano has collaborated with scholars based in United States, China and Spain. Frequent co-authors include Darryle D. Schoepp, Kelly I. Griffey, James A. Monn, David R. Helton, Bryan G. Johnson, Rebecca A. Wright, Mary Jeanne Kallman, Phil Skolnick, Craig R. Salhoff and Matthew J. Valli. Their work appears in journals such as Annals of the New York Academy of Sciences, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact